Tandem Diabetes issues Q4/FY2025 earnings release; specific results not provided in filing excerpt

TANDEM DIABETES CARE INC

2025-FY EPS reported -$3.04 revenue$1,014,736,000

Filing reports issuance of press release for quarter and year ended 12/31/2025.
No financial figures (revenue, EPS, guidance) are available from the submitted text.
Exhibit 99.1 press release was referenced but its content was not included in the user message.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.